Overview
Dr. Akinyemiju is a Professor of Population Health Sciences, Global Health and Ob/Gyn with expertise in cancer epidemiology, cancer biology, global health, and health disparities. Her research expertise and accomplishments have focused on articulating and innovating conceptual and empirical approaches for cancer health disparities research, specifically, disentangling the role of race as a social construct and race-associated biological mechanisms that contribute to cancer disparities. Dr. Akinyemiju also serves as the Vice-Chair for Diversity, Equity, and Inclusion at the Department of Population Health Sciences, and Associate Director for Community Outreach, Engagement, and Equity at the Duke Cancer Institute. Dr. Akinyemiju’s leadership centers around building cross-enterprise, multi-stakeholder coalitions to advance health equity, promote inclusion and diversity, and mentor the next generation of diverse, talented clinical research scholars. Dr. Akinyemiju has received numerous awards, including the 2023 Michelle Winn Inclusive Excellence Award
Dr. Akinyemiju has published over 150 peer-reviewed publications, and her research program has been continuously funded by the National Institutes of Health, Susan G. Komen and the V Foundation. She has mentored (formally and informally) at least 50 trainees and junior faculty, over 50% of whom are URM. Dr. Akinyemiju works extensively with diverse stakeholders, including community-based organizations, policy makers, providers, health system leadership, and leaders from diverse communities to develop impactful, evidence-based interventions to advance health equity
Current Appointments & Affiliations
Recent Publications
End-of-life care quality for American Indians with cancer.
Journal Article J Natl Cancer Inst · February 3, 2025 BACKGROUND: American Indians (AI) experience disparities in cancer outcomes. Little is known about the quality of end-of-life (EOL) care in AI patients with cancer. METHODS: We retrospectively analyzed EOL care for North Carolina patients who died (deceden ... Full text Link to item CiteSupplementary Table 1 from Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North Carolina
Other · November 18, 2024 <p>Supplementary Tables S1a-S1d show estimates for the association between any genomic testing and race and ethnicity among non-Hispanic Black and non-Hispanic White patients by cancer type</p> ... Full text CiteTable 2 from Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North Carolina
Other · November 18, 2024 <p>Percentage of patients who used genomic testing by cancer type, race/ethnicity, and type of test</p> ... Full text CiteRecent Grants
Quality Improvement to Advance Access and Equity to Guideline Concordant Care
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2025 - 2029Disparate Survival, Disparate Workforce: An Integrated Approach to Improving Head and Neck Cancer Outcomes and Diversity in the Oncology Workforce
ResearchCo Investigator · Awarded by National Institute of Dental and Craniofacial Research · 2024 - 2029Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
ResearchMentor · Awarded by National Cancer Institute · 2023 - 2028View All Grants